THERAPEUTIC COMPOUNDS STRUCTURALLY-LINKED TO BACTERIAL POLYPEPTIDES

Details for Australian Patent Application No. 2002246900 (hide)

Owner MEDIMMUNE, INC. WASHINGTON UNIVERSITY

Inventors SAUER, Frederic, G.; LANGERMANN, Solomon; HULTGREN, Scott, J.

Pub. Number AU-A-2002246900

PCT Pub. Number WO2002/059156

Priority 60/257,880 22.12.00 US

Filing date 20 December 2001

Wipo publication date 6 August 2002

International Classifications

A61P 013/00 Drugs for disorders of the urinary system

A61P 035/00 Antineoplastic agents

C07K 016/12 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 039/108 Medicinal preparations containing antigens or antibodies - Escherichia

C07K 014/245 Peptides having more than 20 amino acids

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 019/00 Hybrid peptides

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002246900

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246901-14-membered macrolides derived from leucomycins

2002246899-Pyrazole compounds useful as protein kinase inhibitors